Journal of Biological Chemistry,
Год журнала:
2024,
Номер
300(9), С. 107701 - 107701
Опубликована: Авг. 22, 2024
The
introduction
of
combined
antiretroviral
therapy
(cART)
has
greatly
improved
the
quality
life
human
immunodeficiency
virus
type
1
(HIV-1)-infected
individuals.
Nonetheless,
ever-present
desire
to
seek
out
a
full
remedy
for
HIV-1
infections
makes
discovery
novel
antiviral
medication
compelling.
Owing
this,
new
late-stage
inhibitor,
Lenacapavir/Sunlenca,
an
HIV
multi-phase
suppressor,
was
clinically
authorized
in
2022.
Besides
unveiling
cutting-edge
antivirals
inhibiting
proteins
or
processes,
newer
therapeutics
targeting
host
restriction
factors
hold
promise
curative
care
infections.
Notwithstanding,
bone
marrow
stromal
antigen
2
(BST2)/Tetherin/CD317/HM1.24,
which
entraps
progeny
virions
is
appealing
therapeutic
candidate.
In
this
study,
drug
screening
system
established,
using
Jurkat/Vpr-HiBiT
T
cells,
identify
drugs
that
could
obstruct
release;
candidate
compounds
were
selected
from
Ono
Pharmaceutical
compound
library.
Jurkat
cells
expressing
Vpr-HiBiT
infected
with
NL4-3,
and
amount
release
quantified
indirectly
by
incorporated
into
virions.
Subsequently,
suppressed
viral
used
synthesize
heterocyclic
compound,
HT-7,
reduces
less
cellular
toxicity.
Notably,
HT-7
increased
cell
surface
BST2
coupled
reduction
but
not
Jurkat/KO-BST2
cells.
Seemingly,
impeded
simian
(SIV)
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV-2)
release.
Concisely,
these
results
suggest
release,
following
treatment,
resulted
modulation
expression
HT-7.
Microbiology and Immunology,
Год журнала:
2024,
Номер
68(9), С. 305 - 330
Опубликована: Июль 4, 2024
Abstract
In
middle
to
late
2023,
a
sublineage
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2)
Omicron
XBB,
EG.5.1
(a
progeny
XBB.1.9.2),
is
spreading
rapidly
around
the
world.
We
performed
multiscale
investigations,
including
phylogenetic
analysis,
epidemic
dynamics
modeling,
infection
experiments
using
pseudoviruses,
clinical
isolates,
and
recombinant
viruses
in
cell
cultures
experimental
animals,
use
human
sera
antiviral
compounds,
reveal
virological
features
newly
emerging
variant.
Our
analysis
modeling
suggested
that
two
hallmark
substitutions
EG.5.1,
S:F456L
ORF9b:I5T
are
critical
its
increased
viral
fitness.
Experimental
investigations
on
growth
kinetics,
sensitivity
clinically
available
antivirals,
fusogenicity,
pathogenicity
comparable
those
XBB.1.5.
However,
cryo‐electron
microscopy
revealed
structural
differences
between
spike
proteins
further
assessed
impact
features,
but
it
was
almost
negligible
our
setup.
provide
knowledge
for
understanding
evolutionary
traits
pathogenic
viruses,
population.
Nature Microbiology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 3, 2025
Abstract
SARS-CoV-2
variants
are
mainly
defined
by
mutations
in
their
spike.
It
is
therefore
critical
to
understand
how
the
evolutionary
trajectories
of
spike
affect
virus
phenotypes.
So
far,
it
has
been
challenging
comprehensively
compare
many
spikes
that
emerged
during
pandemic
a
single
experimental
platform.
Here
we
generated
panel
recombinant
viruses
carrying
different
proteins
from
27
circulating
between
2020
and
2024
same
genomic
background.
We
then
assessed
several
phenotypic
traits
both
vitro
vivo.
found
distinct
among
before
after
emergence
Omicron
variants.
Spike
post-Omicron
maintained
enhanced
tropism
for
nasal
epithelium
large
airways
but
displayed,
over
time,
typical
pre-Omicron
Hence,
with
features
pre-
may
continue
emerge
future.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Фев. 26, 2025
Ebsulfur
and
ebselen
derivatives
that
were
proven
to
be
potent
inhibitors
against
the
main
protease
(MPro)
of
SARS-CoV-2
which
is
an
essential
enzyme
for
viral
replication
chosen
study
quantitative
structure–activity
relationship
(QSAR)
analysis
using
a
classical
multiple
linear
regression
(MLR)
machine
learning
approach
random
forest
(RF)
artificial
neural
network
(ANN)
in
order
find
between
molecular
structural
properties
biological
inhibitory
activities.
With
statistical
criteria,
R2
values
MLR,
RF,
ANN
models
training
set
0.83,
0.82,
0.92,
respectively.
The
RMSE
test
considered
model
evaluation,
results
0.27,
0.18,
0.09
models,
Therefore,
was
best-obtained
predicting
MPro
activity
thirteen
new
synthetic
analogs
haven't
tested
assay
before.
Notably,
our
predicted
activities
then
examined
enzyme-based
assays
cytotoxicity
tests,
found
compound
P8
resulted
good
potential
candidate
activity.
Furthermore,
dynamics
simulations
performed
dynamic
interaction
ligand
binding
site;
showed
pathway
mechanism
with
key
residues
surrounding
active
site
MPro,
useful
further
development
derivatives.
The
continued
evolution
of
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
requires
persistent
monitoring
its
subvariants.
Omicron
subvariants
are
responsible
for
the
vast
majority
SARS-CoV-2
infections
worldwide,
with
XBB
and
BA.2.86
sublineages
representing
more
than
90%
circulating
strains
as
January
2024.
To
better
understand
parameters
involved
in
viral
transmission,
we
characterized
functional
properties
Spike
glycoproteins
from
BA.2.75,
CH.1.1,
DV.7.1,
BA.4/5,
BQ.1.1,
XBB,
XBB.1,
XBB.1.16,
XBB.1.5,
FD.1.1,
EG.5.1,
HK.3,
JN.1.
We
tested
their
capacity
to
evade
plasma-mediated
recognition
neutralization,
binding
angiotensin-converting
enzyme
(ACE2),
susceptibility
cold
inactivation,
processing,
well
impact
temperature
on
Spike-ACE2
interaction.
found
that
compared
early
wild-type
(D614G)
strain,
most
subvariants'
evolved
escape
neutralization
by
plasma
individuals
who
received
a
fifth
dose
bivalent
(BA.1
or
BA.4/5)
mRNA
vaccine
improve
ACE2
binding,
particularly
at
low
temperatures.
Moreover,
had
best
affinity
all
temperatures
tested.
processing
is
associated
inactivation.
Intriguingly,
was
significantly
growth
rates
humans.
Overall,
report
Spikes
newly
emerged
relatively
stable
resistant
present
improved
which
associated,
temperatures,
rates.IMPORTANCEThe
gave
rise
wide
range
variants
harboring
new
mutations
glycoproteins.
Several
factors
have
been
transmission
fitness
such
plasma-neutralization
whether
additional
could
be
importance
variants'
characterize
several
glycoprotein
presents
an
further
temperature.
interaction
strongly
rate,
such,
represent
another
parameter
affecting
transmission.
Viruses,
Год журнала:
2025,
Номер
17(4), С. 507 - 507
Опубликована: Март 31, 2025
During
the
COVID-19
pandemic,
severe
acute
respiratory
syndrome
coronavirus
2
(SC2)
infection
was
confirmed
in
various
animal
species
demonstrating
a
wide
host
range
of
virus.
Prior
studies
have
shown
that
ACE2
protein
is
primary
receptor
used
by
virus
to
gain
cellular
entry
and
begin
replication
cycle.
In
previous
studies,
we
demonstrated
human
bat
proteins
can
be
utilized
SC2
viruses
for
entry.
Bats
are
suspected
natural
because
genetic
homology
with
other
coronaviruses.
this
work,
demonstrate
expression
genes
from
common
vampire
(CVB)
(Desmodus
rotundus)
pallid
(PB)
(Antrozous
pallidus),
supports
some
cell
culture.
Two
lines
were
produced,
CVB-ACE2
PB-ACE2,
expressing
these
along
TMPRSS2,
model
previously
established
using
non-permissive
chicken
DF-1
line.
Results
original
Wuhan
lineage
(WA1)
Delta
variant
able
infect
replicate
either
lines.
contrast,
Lambda
Omicron
infected
both
lines,
but
viral
titers
did
not
increase
following
infection.
Viral
detection
immunofluorescence
abundant
spike
(S)
staining
WA1
variants
little
signal
variants.
These
while
CVB
PB
infection,
later
(Lambda
Omicron)
poorly
observations
suggest
more
efficient
adaption
become
less
fit
species.
EBioMedicine,
Год журнала:
2024,
Номер
104, С. 105181 - 105181
Опубликована: Июнь 1, 2024
BackgroundAlthough
several
SARS-CoV-2-related
coronaviruses
(SC2r-CoVs)
were
discovered
in
bats
and
pangolins,
the
differences
virological
characteristics
between
SARS-CoV-2
SC2r-CoVs
remain
poorly
understood.
Recently,
BANAL-20-236
(B236)
was
isolated
from
a
rectal
swab
of
Malayan
horseshoe
bat
found
to
lack
furin
cleavage
site
(FCS)
spike
(S)
protein.
The
comparison
its
with
FCS-deleted
(SC2ΔFCS)
has
not
been
conducted
yet.MethodsWe
prepared
human
induced
pluripotent
stem
cell
(iPSC)-derived
airway
lung
epithelial
cells
colon
organoids
as
organ-relevant
models.
B236,
SARS-CoV-2,
artificially
generated
SC2ΔFCS
used
for
viral
experiments.
To
investigate
pathogenicity
B236
vivo,
we
intranasal
infection
experiments
hamsters.FindingsIn
iPSC-derived
cells,
growth
significantly
lower
than
that
SC2ΔFCS.
A
fusion
assay
showed
S
proteins
less
fusogenic
experiment
hamsters
pathogenic
even
Interestingly,
organoids,
greater
SARS-CoV-2.InterpretationCompared
demonstrated
exhibited
tropism
toward
intestinal
rather
respiratory
cells.
Our
results
are
consistent
previous
report
showing
is
enterotropic
macaques.
Altogether,
our
strengthens
assumption
replicate
primarily
tissues
tissues.FundingThis
study
supported
part
by
AMED
ASPIRE
(JP23jf0126002,
Keita
Matsuno,
Kazuo
Takayama,
Kei
Sato);
SCARDA
Japan
Initiative
World-leading
Vaccine
Research
Development
Centers
"UTOPIA"
(JP223fa627001,
Sato),
Program
on
R&D
new
generation
vaccine
including
modality
application
(JP223fa727002,
Hokkaido
University
Institute
(HU-IVReD)
(JP223fa627005h0001,
Takasuke
Fukuhara,
Matsuno);
Emerging
Re-emerging
Infectious
Diseases
(JP21fk0108574,
Hesham
Nasser;
JP21fk0108493,
Fukuhara;
JP22fk0108617
JP22fk0108146,
Sato;
JP21fk0108494
G2P-Japan
Consortium,
Shinya
Tanaka,
Terumasa
Ikeda,
JP21fk0108425,
Takayama
JP21fk0108432,
Fukuhara
JP22fk0108534,
JP22fk0108511,
Yuki
Yamamoto,
JP22fk0108506,
HIV/AIDS
(JP22fk0410055,
Ikeda;
JP22fk0410039,
Infrastructure
(JP22wm0125008
CREST
(JP21gm1610005,
Takayama;
JP22gm1610008,
JST
PRESTO
(JPMJPR22R1,
Jumpei
Ito);
(JPMJCR20H4,
JSPS
KAKENHI
Fund
Promotion
Joint
International
(International
Leading
Research)
(JP23K20041,
SPRING
(JPMJSP2108
Shigeru
Fujita);
Grant-in-Aid
Scientific
C
(22K07103,
Ikeda);
B
(21H02736,
Fukuhara);
Early-Career
Scientists
(22K16375,
20K15767,
Core-to-Core
(A.
Advanced
Networks)
(JPJSCCA20190008,
Fellow
DC2
(22J11578,
Keiya
Uriu);
DC1
(23KJ0710,
Yusuke
Kosugi);
Excellent
Young
Researchers
(LEADER)
(to
Innovative
Smart
Education
(WISE)
1801
Ministry
Education,
Culture,
Sports,
Science
Technology
(MEXT)
Naganori
Nao);
Health,
Labour
Welfare
(MHLW)
under
grant
23HA2010
Nao
Cooperative
(Joint
Usage/Research
Center
program)
Life
Medical
Sciences,
Kyoto
Project
Science,
Tokyo
Ikeda
Biochemical
Foundation
Takeda
Mochida
Memorial
Pharmaceutical
Naito
Hokuto
Bioscience
Tomokazu
Tamura);
Hirose
Mitsubishi
Sato).
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
acquired
multiple
mutations
since
its
emergence.
Analyses
of
the
SARS-CoV-2
genomes
from
infected
patients
exhibit
a
bias
toward
C-to-U
mutations,
which
are
suggested
to
be
caused
by
apolipoprotein
B
mRNA
editing
enzyme
polypeptide-like
3
(APOBEC3,
A3)
cytosine
deaminase
proteins.
However,
role
A3
enzymes
in
replication
remains
unclear.
To
address
this
question,
we
investigated
effect
family
proteins
on
THP-1
cells
lacking
A3A
A3G
genes.
The
Wuhan,
BA.1,
and
BA.5
variants
had
comparable
viral
parent
A3A-to-A3G-null
THP-1-ACE2
cells.
On
other
hand,
infectivity
these
were
abolished
series
passage
experiments
over
20
days.
In
contrast
previous
reports,
observed
no
evidence
for
A3-induced
mutagenesis
experiments.
Furthermore,
our
analysis
large
number
publicly
available
did
not
reveal
conclusive
mutagenesis.
Taken
together,
studies
suggest
that
can
positively
contribute
replication,
however
is
deaminase-independent.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Май 14, 2024
Summary
COVID-19
pandemic
in
Brazil
was
characterized
by
the
sequential
circulation
of
SARS-CoV-2
lineages
B.1.1.33,
and
variants
Zeta
(P.2),
Gamma
(P.1/P.1.*),
Delta
(B.1.617.2/AY.*),
Omicron
(BA.*).
Our
research
aimed
to
compare
biological
traits
these
analyzing
aspects
viral
replication
including
binding,
entry,
RNA
replication,
protein
production.
We
demonstrated
that
capacity
varies
depending
on
cell
type,
with
BA.1
exhibiting
lowest
human
pulmonary
cells.
Additionally,
nucleocapsid
proteoforms
generated
during
infection
exhibit
distinct
patterns
across
variants.
findings
suggest
factors
beyond
initial
stages
virus
entry
influence
efficiency
among
different
Thus,
our
study
underscores
significance
role
proteins
shaping
replicative
characteristics
Author
summary
The
emergence
presents
specific
properties
such
as
response
antibodies,
pathogenicity
detection
diagnostic
tests.
presented
a
particular
pattern
global
geographic
regions.
Despite
cessation
pandemic,
officially
declared
World
Health
Organization
2023,
new
continue
emerge
while
virus-cell
interaction
contribute
have
not
yet
been
completely
understood.
In
study,
we
compared
circulated
verifying
production
proteins.
results
indicate
variant
has
reduced
lung
also
observed
vary
according
variant.
These
differences
could
help
explain
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Май 5, 2024
Abstract
The
introduction
of
combined
antiretroviral
therapy
(cART)
has
greatly
improved
the
quality
life
human
immunodeficiency
virus
type
1
(HIV-1)-infected
individuals.
Nonetheless,
ever-present
desire
to
seek
out
a
full
remedy
for
HIV-1
infections
makes
discovery
novel
antiviral
medication
compelling.
Owing
this,
new
late-stage
inhibitor,
Lenacapavir/Sunlenca,
an
HIV
multi-phase
suppressor,
was
clinically
authorized
in
2022.
Besides
unveiling
cutting-edge
antivirals
inhibiting
proteins
or
processes,
newer
therapeutics
targeting
host
restriction
factors
hold
promise
curative
care
infections.
Notwithstanding,
bone
marrow
stromal
antigen
2
(BST2)/Tetherin/CD317/HM1.24,
which
entraps
progeny
virions
is
appealing
therapeutic
candidate.
In
this
study,
drug
screening
system
established,
using
Jurkat/Vpr-HiBiT
T
cells,
identify
drugs
that
could
obstruct
release;
candidate
compounds
were
selected
from
Ono
Pharmaceutical
compound
library.
Jurkat
cells
expressing
Vpr-HiBiT
infected
with
NL4-3,
and
amount
release
quantified
indirectly
by
incorporated
into
virions.
Subsequently,
suppressed
viral
used
synthesize
heterocyclic
compound,
HT-7,
reduces
less
cellular
toxicity.
Notably,
HT-7
increased
cell
surface
BST2
coupled
reduction
but
not
Jurkat/KO-BST2
cells.
Seemingly,
impeded
simian
(SIV)
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV-2)
release.
Concisely,
these
results
suggest
release,
following
treatment,
resulted
modulation
expression
HT-7.
Importance
A
collection
scientific
strategies
been
revealed
find
long-term
cure
infection.
One
techniques,
approach,
involves
harnessing
late
events
are
targeted
current
medication.
regulator
assembly
Gag
protein,
emerged
as
prospective
inhibitor.
We
set
up
high-efficiency,
economically
viable,
facile
identification
inhibitors.
Herein,
we
discovered
inhibits
This
newly
high-
performance
testing
technique
can
be
employed
virological
research
investigating
HIV-
processes.
Viruses,
Год журнала:
2024,
Номер
16(7), С. 1141 - 1141
Опубликована: Июль 16, 2024
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
acquired
multiple
mutations
since
its
emergence.
Analyses
of
the
SARS-CoV-2
genomes
from
infected
patients
exhibit
a
bias
toward
C-to-U
mutations,
which
are
suggested
to
be
caused
by
apolipoprotein
B
mRNA
editing
enzyme
polypeptide-like
3
(APOBEC3,
A3)
cytosine
deaminase
proteins.
However,
role
A3
enzymes
in
replication
remains
unclear.
To
address
this
question,
we
investigated
effect
family
proteins
on
myeloid
leukemia
cell
line
THP-1
lacking
A3A
A3G
genes.
The
Wuhan,
BA.1,
and
BA.5
variants
had
comparable
viral
parent
A3A-to-A3G-null
cells
stably
expressing
angiotensin-converting
(ACE2)
protein.
On
other
hand,
infectivity
these
were
abolished
THP-1-ACE2
series
passage
experiments
over
20
days.
In
contrast
previous
reports,
observed
no
evidence
A3-induced
mutagenesis
experiments.
Furthermore,
our
analysis
large
number
publicly
available
did
not
reveal
conclusive
for
mutagenesis.
Our
studies
suggest
that
can
positively
contribute
replication;
however,
is
deaminase-independent.